Drug Trial Radar · NCT05623189
HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
218
Actual
Start
Dec 27, 2022
Primary completion
Mar 31, 2025
Study completion Mar 31, 2025
Sponsor
- Lead sponsor
- HighTide Therapeutics (Hong Kong) LimitedIndustry
- Sponsor type
- Industry
- First posted
- Nov 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 2b, multicenter, randomized, double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes mellitus or pre-diabetes.
Conditions
- Nonalcoholic Steatohepatitis (NASH)
- Type 2 Diabetes
Interventions
HTD1801Drug
HTD1801,1250 mg, BID
PlaceboDrug
Placebo, BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: Up to 60 Weeks
Locations
45 sites in 3 countries. Site status is shown where the registry gives one.
The Institute for Liver Health (Arizona Liver Health)
Chandler, Arizona
Arizona Liver Health - Glendae
Peoria, Arizona
Adobe Clinical Research LLC
Tucson, Arizona
Aizona Liver Health
Tucson, Arizona
San Fernando Valley Health Institute
Canoga Park, California
Clinnova Research Solutions
Garden Grove, California
Catalina Research Institute
Montclair, California
California Liver Institute
Pasadena, California
Inland Empire Liver Foundation
Rialto, California
Excel Medical Clinical Trials, LLC
Boca Raton, Florida
Tampa Bay Medical Research, Inc.
Clearwater, Florida
Covenant Metabolic Specialists - Fort Meyers
Fort Myers, Florida
Evolution Clinical Trials, Inc.
Hialeah Gardens, Florida
ClinCloud LLC Maitland
Maitland, Florida
Clinical Pharmacology of Miami, LLC
Miami, Florida
Panax Clinical Research
Miami Lakes, Florida
Floridain Clinical Research
Miami Lakes, Florida
Covenant Metabolic Specialists - Sarasota
Sarasota, Florida
Theia Clinical Research LLC
Temple Terrace, Florida
ClinCloud LLC Melbourn
Viera, Florida
Metabolic Research Institute, Inc.
West Palm Beach, Florida
Conquest Research
Winter Park, Florida
Louisvill Metabolic and Atherosclerosis Research Center (L-MARC)
Louisville, Kentucky
Tandem Clinical Research
Marrero, Louisiana
Henry Ford Hospital
Detroit, Michigan
Jubilee Clinical Research, Inc.
Las Vegas, Nevada
Tandem Clinical Research GI - New York
New York, New York
Lucas Research - Diabetes and Endocrinology
Morehead City, North Carolina
Clinical Research Institute of Ohio
Westlake, Ohio
Palmetto Clinical Research
Summerville, South Carolina
ClinSearch LLC
Chattanooga, Tennessee
Premier Research
Clarksville, Tennessee
Texas Clinical Research Institute
Arlington, Texas
Pinnacle Clinical Research
Austin, Texas
South Texas Research Institute
Brownsville, Texas
EPIC Medical Research
DeSoto, Texas
Pinnacle Research, Georgetown TX
Georgetown, Texas
Quality Research, Inc.
San Antonio, Texas
Sun Research Institute
San Antonio, Texas
Pinnacle Clinical Research San Antonio
San Antonio, Texas
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.